Angela R. Bradbury, MD
Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Full Member, Abramson Cancer Center, Cancer Control Research Program, Philadelphia, PA
Biomedical Review Panelist , University Research Foundation Grants Program, University of Pennsylvania
COAP Member , Department of Medical Ethics & Health Policy
Co-Leader, Cancer Control Research Program, Abramson Cancer Center
Innovation Faculty Member , Penn Center for Cancer Care at Abramson Cancer Center
Department: Medicine
Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-106
3400 Civic Center Boulevard
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-106
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-615-3360
Fax: 215-615-3349
Fax: 215-615-3349
Education:
BA (Biology)
University of Virginia, 1993.
PB (Post-Baccalaureate)
University of South Carolina, 1994.
MD (Internal Medicine)
Medical University of South Carolina, 1999.
Permanent linkBA (Biology)
University of Virginia, 1993.
PB (Post-Baccalaureate)
University of South Carolina, 1994.
MD (Internal Medicine)
Medical University of South Carolina, 1999.
Selected Publications
Erickson CM, Langlois CM, Wood EM, Mim R, Howe S, Ofidis D, Egleston BL, Harkins K, Largent EA, Roberts JS, Reiman EM, Denkinger M, Ashton NJ, Karlawish J, Bradbury AR, Langbaum JB.: Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning APOE and pTau-217 results. Alzheimers Dement (N Y) 11: e70177, Nov 2025.Cocchella G, Phung L, Wood E, Egleston B, Hoffman-Andrews L, Brown S, Ofidis D, Mim R, Griffin H, Fetzer D, Owens A, Domchek S, Pyeritz R, Katona BW, Kallish S, Sirugo G, Weaver J, Nathanson KL, Rader DJ, Bradbury AR.: An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobank. Eur J Med Genet 78: 105061, Nov 2025.
Henderson TO, Egleston B, Howe S, Allen MA, Mim R, Fleisher LG, Elkin EB, Oeffinger KC, Krull KR, Ofidis D, Mcleod B, Griffin H, Wood EM, Cacioppo CN, Brown S, Perpich M, Armstrong GT, Bradbury AR.: The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer Survivors. medRxiv Oct 2025.
Chavez-Yenter D, Fetzer D, Egleston B, Domchek S, Fleisher L, Wagner LI, Wen KY, Karpink K, Gutstein L, Posen S, Selmani E, McLeod B, Anantharajah A, Brown S, Cacioppo C, Cappadocia J, Ebrahimzadeh JE, Falcone D, Howe S, Langer C, McCarthy-Wood B, Weinberg M, Bradbury AR.: The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing. BMC Cancer 25: 1642, Oct 2025.
Lee KT, McLeod B, Egleston B, Brown S, Howe S, Fetzer D, Gutstein L, Cacioppo C, Clark D, Domchek SM, Ebrahimzadeh J, Falcone D, Ofidis D, Griffin H, Mim R, Hernandez S, Fleisher L, Karpink K, Selmani E, Tahsin A, Wagner L, Weinberg M, Yi-Wen K, Wood E, Bradbury AR.: An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial. JMIR Res Protoc 14: e72515, Aug 2025.
Kimberley T. Lee, Carley Geiss, Hayden J. Fulton, Dannelle Charles, Brian D. Gonzalez, Heather S.L. Jim, N. Lynn Henry, Dawn L. Hershman, Shelley S. Tworoger, Angela Bradbury, Oluwadamilola M. Fayanju, Susan T. Vadaparampil and Clement K. Gwede: Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences. Clinical Breast Cancer July 2025.
Trieu P, Fetzer D, McLeod B, Schweickert K, Gutstein L, Egleston B, Domchek S, Fleisher L, Wagner L, Wen KY, Cacioppo C, Ebrahimzadeh JE, Falcone D, Langer C, Wood E, Karpink K, Posen S, Selmani E, Bradbury AR.: Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study. JMIR Form Res 9: e56282, May 2025.
Demarest K, Anantharajah A, Maxwell KN, Rohanizadegan M, Bradbury A, Nathanson KL, McCarthy AM, Domchek SM, Nayak A, Shah PD.: Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer. JAMA Netw Open 8: e2460312, Feb 2025.
Snyder GG, Clay D, Karley S, Pipito S, Mueller R, Bradbury A, Maxwell K, Nathanson KL, Rohanizadegan M, Shah P, Domchek SM, Long JM, Katona BW.: Assessment of barriers to pancreatic cancer surveillance in high-risk individuals. J Genet Couns 2025.
Kilbride MK, Chavez-Yenter D, Wong B, Roberts JS, Park J, Iuliano J, Bradbury AR.: Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk. Am J Med Genet A 2025.